Clonidine is a blood pressure medication that has become widely used in mental health treatment, particularly for ADHD, PTSD, anxiety, insomnia, and substance withdrawal. It works by reducing the activity of norepinephrine, a brain chemical tied to alertness, stress responses, and the “fight or flight” system. That calming effect on the nervous system is what makes it useful across so many psychiatric conditions.
Only one mental health use is formally FDA-approved: treating ADHD in children and adolescents ages 6 to 17. Everything else, including its use in adults with anxiety, PTSD, or withdrawal symptoms, is prescribed off-label. Off-label doesn’t mean unproven or unsafe; it simply means the manufacturer hasn’t sought formal approval for that specific condition.
ADHD in Children and Adolescents
The extended-release form of clonidine (brand name Kapvay) is FDA-approved for ADHD in patients aged 6 to 17, either on its own or alongside a stimulant like methylphenidate or amphetamine. It’s most often added when stimulants alone aren’t controlling symptoms well enough, or when side effects like trouble sleeping or irritability need to be managed.
Clonidine doesn’t work the same way stimulants do. Rather than boosting dopamine, it dials down norepinephrine signaling, which helps with hyperactivity, impulsivity, and emotional reactivity. It’s especially useful for kids who have prominent hyperarousal symptoms: restlessness, difficulty winding down at night, or emotional outbursts. The approved dose range tops out at 0.4 mg per day, split between a morning and bedtime dose, with the larger portion typically given at bedtime because drowsiness is common.
For adults with ADHD, clonidine is sometimes prescribed off-label, but the evidence base is much thinner and there is no FDA-approved adult ADHD indication.
PTSD and Trauma-Related Nightmares
People with PTSD often have an overactive norepinephrine system. This drives hypervigilance, an exaggerated startle response, difficulty falling asleep, and vivid trauma-related nightmares. Clonidine quiets that system by reducing norepinephrine release in a brain region called the locus coeruleus, which acts as the brain’s alarm center.
One prospective study found that seven out of nine PTSD patients (about 78%) experienced improvement in nightmares with clonidine, at doses ranging from 0.1 to 0.3 mg per day. A crossover trial also showed significant improvement in hyperarousal symptoms. Newer research suggests clonidine may help restore normal REM sleep patterns, which could play a role in how the brain processes and files away traumatic memories rather than replaying them.
When compared head-to-head with prazosin (another blood pressure drug commonly used for PTSD nightmares), a meta-analysis of two studies found no significant difference between the medications in reducing nightmares. This suggests clonidine is a reasonable alternative, though the overall evidence base remains small and more rigorous trials are needed.
Anxiety and Panic Symptoms
Clonidine is used off-label for anxiety, particularly when physical symptoms of anxiety are prominent: racing heart, sweating, trembling, or a general sense of being “wired.” In a controlled trial of 23 patients with generalized anxiety and panic disorder, clonidine outperformed placebo at reducing anxiety attacks and what researchers described as “psychic” symptoms like dread and apprehension. Physical symptoms like muscle tension and GI distress responded less consistently.
About 17% of patients in that study actually felt worse on the medication, likely because clonidine’s effects on the nervous system are complex. It’s not a first-line treatment for anxiety disorders, but it fills a niche for people who can’t tolerate standard options or who need something to blunt the acute physical surge of a panic episode.
Substance Withdrawal
Clonidine is one of the most commonly used medications for managing the autonomic storm that comes with opioid, alcohol, and benzodiazepine withdrawal. When someone stops using these substances, norepinephrine activity surges, causing sweating, rapid heartbeat, agitation, muscle aches, and insomnia. Clonidine directly counteracts that surge.
During opioid withdrawal specifically, clonidine is used to ease the sweating, elevated heart rate, and restlessness that peak in the first few days. It does not address cravings or the psychological dimensions of withdrawal, so it’s typically part of a broader treatment plan. Guidelines also support using clonidine for mild to moderate symptoms during stimulant withdrawal when agitation persists despite other interventions. The average course runs about 15 days, after which the medication is tapered off.
Sleep Problems
Clonidine’s sedating effect, which is a side effect in some contexts, becomes the main benefit when sleep is the target. It’s commonly prescribed off-label for insomnia in children and adolescents, particularly those with ADHD or anxiety who struggle to fall asleep.
A study of children and adolescents found that clonidine significantly reduced the time it took to fall asleep, with the strongest effects in those whose baseline sleep latency exceeded 60 minutes, those with mood or anxiety disorders or ADHD, and those who used it for more than 14 days. Females and older adolescents (ages 13 to 24) also showed greater improvement. Subjective sleep quality improved as well, particularly in how long it took to fall asleep and overall sleep satisfaction.
How Clonidine Compares to Guanfacine
Guanfacine is the other blood pressure medication frequently used in psychiatry, and the two get compared often. The key difference is selectivity. Clonidine activates three subtypes of the same receptor (alpha-2A, 2B, and 2C), while guanfacine targets mainly alpha-2A receptors in the prefrontal cortex. That narrower target is why guanfacine tends to cause less sedation and fewer blood pressure drops.
Clonidine acts faster, with effects beginning within 30 to 60 minutes and peaking at 2 to 4 hours. This makes it more useful for acute situations like calming a panic response, easing withdrawal symptoms, or helping someone fall asleep quickly. Guanfacine’s longer, smoother action makes it better suited for steady, all-day ADHD symptom control with fewer peaks and valleys. In practice, clonidine is often the choice when sedation is actually desirable (bedtime dosing for sleep, acute agitation) and guanfacine when daytime alertness matters more.
Side Effects and Tapering
The most common side effects are drowsiness, dry mouth, dizziness, and low blood pressure. Sedation is the most prominent and tends to be strongest in the first few weeks before the body adjusts. Because clonidine lowers blood pressure, lightheadedness when standing up quickly is common, especially at higher doses.
The most important safety concern is what happens if you stop taking it abruptly. In a study of patients who suddenly stopped clonidine, nearly all experienced a rebound spike in heart rate and blood pressure. Half had noticeable symptoms, and about one in five had symptoms severe enough to require medical intervention, occurring anywhere from 12 to 60 hours after the last dose. This rebound is caused by the sympathetic nervous system surging back after being suppressed. Tapering the dose gradually, reducing by no more than 0.1 mg every 3 to 7 days, prevents this. You should never stop clonidine cold turkey, even if you’re taking a low dose for a psychiatric condition rather than for blood pressure.